| Feature | Specification |
|---|---|
| Application |
Prenatal screening Pre-eclampsia |
| Disorders |
Common Trisomies Pre-Eclampsia |
This solid-phase, two-site fluoroimmunometric assay is based on the direct sandwich technique in which two antibodies are directed against two separate antigenic determinants on the PlGF molecule.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
| Application |
Prenatal screening
Pre-eclampsia
|
|---|---|
| Brand |
DELFIA®
|
| Detection Modality |
Time-Resolved Fluorescence (TRF)
|
| Disorders |
Common Trisomies
Pre-Eclampsia
|
| Instrument Compatibility |
AutoDELFIA
Victor 2D
|
| Regulatory Status |
CE-IVD marked (Notified Body 0537)
|
| Sample Type |
Serum
|
| Technology |
DELFIA
|
| Unit Size |
96 assays
|
Are you looking for resources, click on the resource type to explore further.
Brochure for DELFIA prenatal screening solutions and assays including traditional biochemical screening, pre-eclampsia
Brochure for pre-eclampsia screening with the PlGF 1-2-3 kit in the 1st trimester of pregnancy.
We are here to answer your questions.